Elevated CCL5 levels correlate with increased tumor burden following neoadjuvant chemotherapy (110), and gene expression profiling of residual tumors reveals enrichment of CCL5, suggesting its role in recruiting macrophages and fostering recurrence (111). This evidence concerns the gene CCL5 and neoplasm.